drugset / Trial / NCT06781333
Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to test if adding one infusion of mesenchymal stem cells to the current treatment with antipsychotic medication may help control behavioral problems in people with a diagnosis of moderate to severe Alzheimer's disease.
Timeline
- Start
- 2025-04-29
- Primary completion
- 2027-12-15
- Completion
- 2027-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hMSC | Cell therapy | 2.5e+07 cells | Intravenous |